Opus Genetics (IRD) Other Accumulated Expenses (2019 - 2025)
Opus Genetics (IRD) reported Other Accumulated Expenses of $268000.0 for Q3 2025, up 325.4% year-over-year from $63000.0 in Q3 2024, and up 1.13% on a QoQ basis from $265000.0 in Q2 2025.
Opus Genetics (IRD) has 7 years of Other Accumulated Expenses data on file, last reported at $268000.0 in Q3 2025.
- Quarterly Other Accumulated Expenses rose 325.4% year-over-year to $268000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $268000.0 (up 325.4% YoY) and the FY2024 annual result came in at $606000.0, up 753.52% from the prior year.
- Other Accumulated Expenses advanced to $268000.0 in Q3 2025 per IRD's latest filing, from $265000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $606000.0 in Q4 2024 and bottomed at $8000.0 in Q3 2021.
- The 5-year median for Other Accumulated Expenses is $74000.0 (2022), against an average of $129789.5.
- The widest annual swing landed in 2022, when Other Accumulated Expenses soared 825.0%; it then plunged 57.49% in 2023.
- Tracing IRD's Other Accumulated Expenses over 5 years: stood at $80000.0 in 2021, then surged by 108.75% to $167000.0 in 2022, then sank by 57.49% to $71000.0 in 2023, then surged by 753.52% to $606000.0 in 2024, then sank by 55.78% to $268000.0 in 2025.
- Per Business Quant, the three latest IRD Other Accumulated Expenses figures stand at $268000.0 (Q3 2025), $265000.0 (Q2 2025), and $380000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 380,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Sep 30, 2022 | 74,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 26,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 9,000.00 |